首页> 外国专利> Method for producing an antitumoral vaccine based on surface endothelial cell antigens

Method for producing an antitumoral vaccine based on surface endothelial cell antigens

机译:基于表面内皮细胞抗原的抗肿瘤疫苗的生产方法

摘要

Accordingly to the method of the preparing of the tumor vaccine with the use of endothelial cells, live endothelial cells are treated with a protease at mild (non-deadly for cells) conditions, the splitted surface antigens are collected, the treatment of live endothelial cells is repeated after intervals which are necessary for the recovery of the surface antigens by the cells, surface antigens are accumulated until their necessary quantity is reached, the quality of the vaccine is controlled thereafter. The technical result obtained with the use of this invention consists in the enhancement of the efficiency of oncological disease treatment due to the damage of the tumor vessels caused by overcoming of the immune tolerance of organism to the endothelial cells (EC) of tumor vessels. Here one means the overcoming of immune tolerance namely to activated EC, which allows to damage mainly to the tumor vessels by the immune system.
机译:根据使用内皮细胞制备肿瘤疫苗的方法,在温和的条件下(对细胞而言是非致命的)用蛋白酶处理活的内皮细胞,收集分裂的表面抗原,处理活的内皮细胞。在细胞回收表面抗原所必需的时间间隔后,重复上述步骤,积累表面抗原直至达到其必需的量,然后控制疫苗的质量。使用本发明获得的技术结果在于由于克服了生物体对肿瘤血管内皮细胞(EC)的免疫耐受性而引起的肿瘤血管损伤而提高了肿瘤疾病治疗的效率。在这里,一种手段是克服免疫耐受即激活的EC,这主要允许免疫系统对肿瘤血管的损害。

著录项

  • 公开/公告号US9844586B2

    专利类型

  • 公开/公告日2017-12-19

    原文格式PDF

  • 申请/专利权人 PETR GENRIEVICH LOKHOV;

    申请/专利号US20090545518

  • 发明设计人 PETR GENRIEVICH LOKHOV;

    申请日2009-08-21

  • 分类号A61K39;A61P35;C12N5/071;C12N5/09;

  • 国家 US

  • 入库时间 2022-08-21 12:57:57

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号